CN103536560A - Ceftezole sodium composition powder for injection - Google Patents

Ceftezole sodium composition powder for injection Download PDF

Info

Publication number
CN103536560A
CN103536560A CN201310481840.XA CN201310481840A CN103536560A CN 103536560 A CN103536560 A CN 103536560A CN 201310481840 A CN201310481840 A CN 201310481840A CN 103536560 A CN103536560 A CN 103536560A
Authority
CN
China
Prior art keywords
chitosan
sodium
injection
ceftezole
ceftezole sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310481840.XA
Other languages
Chinese (zh)
Inventor
汪六一
汪金灿
汪宁卿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Original Assignee
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Weikang Pharmaceutical Qianshan Co Ltd filed Critical Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority to CN201310481840.XA priority Critical patent/CN103536560A/en
Publication of CN103536560A publication Critical patent/CN103536560A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a ceftezole sodium composition powder for injection, and belongs to the field of medicine and medicine preparation technology. The ceftezole sodium composition powder comprises following raw material ingredients, by weight, 7.26 to 9.17 parts of ceftezole sodium, 5.78 to 7.67 parts of chitosan nanoparticle, and 81.38 to 87.10 parts of injection water. Advantages of the ceftezole sodium composition powder are that: 1) in vitro antibacterial activity spectrum is wider, and poor antibacterial activity of ceftezole sodium on pneumococcus, pseudomonas aeruginosa and acinetobacter is improved greatly; 2) the nanoparticle medicine carrier is capable of changing membrane transport mechanisms, and increasing medicine permeability against biological membranes, and is beneficial for exhibition of pharmacological functions in cells; 3) ceftezole sodium coated by the nanoparticle carrier is rapidly gathered at primary organs, such as liver and spleen, of the reticuloendothelial system along veins, so that toxicity caused by nonspecific gathering of medicine is reduced; and 4) the chitosan nanoparticle can be used as a freeze-dried skeleton agent of the freeze-dried powder injection instead of mannitol so as to avoid active effects of mannitol on human bodies.

Description

Ceftezole sodium used for injection composition powder injection
Technical field:
The present invention relates to medicine and medicine manufacture technology field, relate in particular to a kind of Ceftezole sodium used for injection composite freeze-dried powder.
Background technology:
Chemical name is: (6R, 7R)-3-[(1,3,4-thiadiazoles-2-yl) sulphomethyl]-8-oxo-7-[2-(1H-tetrazolium-1-yl) acetylamino]-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2 sodium formate.
Character: this product for white to light yellow crystalline powder, odorless, have and draw moistly, structural formula is as follows:
Figure BDA0000395838720000011
Cefobutazine sodium is semisynthetic cephalosporins derivatives, and its mechanism of action is the synthetic antibacterial activity of bringing into play by anti-bacteria cell wall.This product is widely distributed in vivo, wherein the highest with kidney, is followed successively by serum, liver, lung, the heart, spleen.Indication is respiratory system infection, urinary system infection, septicemia, peritonitis.
Cefobutazine sodium has antibacterial activity to following antibacterial: 1, aerobic gram positive bacteria: staphylococcus aureus, streptococcus pneumoniae, micrococcus scarlatinae.2, aerobic gram-negative bacteria: escherichia coli, klebsiella pneumoniae, Bacillus proteus.Antimicrobial spectrum is narrower, and streptococcus pneumoniae, Pseudomonas aeruginosa, acinetobacter calcoaceticus and stenotrophomonas maltophilia are to its drug resistance.Many and other antibiotic coupling clinically, but occurred as untoward reaction such as anaphylaxis, granulocytopenia, eosinophilia, thrombocytopenia.
Patient compliance is major issue in the treatment of infected by microbes.Preparation various active thing is that single dosage form can improve patient compliance and causes remarkable clinical benefit.Yet effective in order to become medicine, this single dosage form must meet multiple ductile and require as stability.
Chitosan is a kind of aminopolysaccharide polymer, is that the chitin by natural non-activity obtains after deacetylation.Structure and the cellulose of chitosan are quite similar, and just the acetylamino on sugar ring C2 has replaced hydroxyl, and this acetylamino gives chitosan special characteristic, make it can be for pharmaceutical preparation aspect.Chitosan is easy to dissolve in weak acid solvent, it is worthy of note especially in solution after dissolving and contains amino, and these amino are by carrying out anti-bacteria in conjunction with negatron.Chitosan is alkalescence, has very strong hydrophilic, can be with hydrochloric acid and acetic acid etc. the inorganic or synthetic salt of organic acid.A lot of physiologically actives of chitosan make it at field of medicaments, have a wide range of applications.
Chitosan nano is the microgranule that a kind of particle diameter is less than 100nm as novel anti-biotic material, this nanoparticle is due to the high-specific surface area of antibacterial and the special effects of high reaction activity, greatly improved whole antibacterial effect, can make microorganism comprise that the Growth and reproduction of antibacterial, fungus, yeast, algae and virus etc. keeps lower level.The various goods made from chitosan nano, can effectively avoid the propagation of antibacterial, and can, when thering is slow release, targeting and using separately as a kind of pharmaceutical carrier, there is weak antibiotic, bacteriostasis.
Summary of the invention:
Object of the present invention is exactly for the cefobutazine sodium antibacterials containing single component, and a kind of antimicrobial spectrum is wider, antibacterial action is stronger cefobutazine sodium antibacterial combination and pharmaceutical preparation thereof are provided.
Technical problem to be solved by this invention realizes by the following technical solutions.
The invention provides ceftezole composition of sodium, the prescription of said composition consists of cefobutazine sodium, chitosan nano, water for injection, it is characterized in that: chitosan nano can be used as skeleton agent, solubilizing agent, the synergist (chitosan nano itself has certain antibacterial activity, plays synergetic antibacterial effect after combining with cefobutazine sodium) of cefobutazine sodium.
A composite freeze-dried powder, is characterized in that, the material composition that comprises following weight portion:
7.26~9.17 parts of cefobutazine sodiums
5.78~7.67 parts of chitosan nanos
81.38~87.10 parts of waters for injection
The preparation method that the invention provides a kind of Ceftezole sodium used for injection composite freeze-dried powder, is characterized in that, comprises the steps:
(1) preparation of chitosan nano:
1) will after the pulverizing of chitosan powder, through 100 eye mesh screens, sieve;
2) the chitosan powder that takes 100g at room temperature adds 0.1mol/l acetic acid solution 40L, and magnetic agitation, dissolves chitosan completely, obtains chitosan acetic acid solution;
3) with 1%NaOH, regulate pH=5.0;
4) add 1% sodium tripolyphosphate 1667g to chitosan acetic acid solution under stirring, making chitosan/sodium tripolyphosphate mass ratio is 6:1, and the electrostatic interaction by zwitterion is cross-linked into nanoparticle;
5) by 4 ℃ of high speed centrifugation 30min of above-mentioned colloid solution, collect lower sediment, with after pure water washing 3 times, the dry chitosan nano that obtains of cooling final vacuum, moisture is lower than 2%, particle diameter≤100nm, zeta current potential is about 15mv;
(2) preparation of Ceftezole sodium used for injection composite freeze-dried powder:
1) chitosan nano of recipe quantity is slowly joined in the water for injection of recipe quantity, stir while adding to dissolving;
2) add cefobutazine sodium the extremely clarification of stirring and dissolving of recipe quantity;
3) with the buffer salt of sodium dihydrogen phosphate and sodium hydrogen phosphate, adjust pH to 5.1, add 0.1% active carbon to stir 30 minutes, filtering active carbon, medicinal liquid is again through 0.45 μ m and 0.22 μ m filtering with microporous membrane, detect intermediate content, by cefobutazine sodium, every bottle of 40mg calculates loading amount;
4) according to testing requirement fill, after half tamponade, send in freezer dryer, be cooled to-40 ℃, be incubated 2 as a child, be slowly warming up to-5 ℃~0 ℃ sublimation drying, then be warming up to after 35 ℃, be incubated 3 hours, lyophilization finishes, outlet.
Beneficial effect of the present invention is:
The invention provides the compositions that a kind of cefobutazine sodium mixes in 1:0.8 ratio with chitosan nano, and make injection freeze-dried powder as antibacterials for clinical.The inventor is by consulting a large amount of documents and materials and test of many times screening demonstration, said composition tool has the following advantages: 1) antibacterial activity in vitro spectrum is wider, has improved the anti-streptococcus pneumoniae of single cefobutazine sodium, Pseudomonas aeruginosa, the poor feature of acinetobacter calcoaceticus isoreactivity; 2) drug-carrying nanometer particle can change film operative mechanism, increases medicine to biomembranous permeability, is conducive to medicine drug effect performance in cell; 3) cefobutazine sodium of nano-carrier parcel is gathered in rapidly the major organs of the reticuloendothelial systems such as liver and spleen along vein, has reduced the toxicity that the nonspecific gathering due to medicine causes; 4) the alternative mannitol of chitosan nano, as the lyophilizing skeleton agent of freeze-dried powder, has been eliminated the active function of mannitol to human body.
The specific embodiment:
Following examples are used for illustrating the present invention, yet these embodiment do not limit the scope of the invention.
The preparation of embodiment mono-, Ceftezole sodium used for injection composite freeze-dried powder, in 1000.
Prescription:
Cefobutazine sodium 40g
Chitosan nano 32g
Water for injection 2000ml
2. preparation technology:
The chitosan nano that takes 32g slowly joins in the water for injection of 2000ml, stirs while adding to dissolving.
The cefobutazine sodium the extremely clarification of stirring and dissolving that add 40g.
With the buffer salt of sodium dihydrogen phosphate and sodium hydrogen phosphate, adjust pH to 5.1, add 0.1% active carbon to stir 30 minutes, filtering active carbon, medicinal liquid is again through 0.45 μ m and 0.22 μ m filtering with microporous membrane, detect intermediate content, by cefobutazine sodium, every bottle of 40mg calculates loading amount.
According to testing requirement fill, after half tamponade, send in freezer dryer, be cooled to-40 ℃, be incubated 2 as a child, be slowly warming up to-5 ℃~0 ℃ sublimation drying, then be warming up to after 35 ℃, be incubated 3 hours, lyophilization finishes, outlet.
The preparation of embodiment bis-, Ceftezole sodium used for injection composite freeze-dried powder, in 1000.
1. write out a prescription:
Cefobutazine sodium 40g
Chitosan nano 25g
Water for injection 2000ml
2. preparation technology:
The chitosan nano that takes 25g slowly joins in the water for injection of 2000ml, stirs while adding to dissolving.
The cefobutazine sodium the extremely clarification of stirring and dissolving that add 40g.
With the buffer salt of sodium dihydrogen phosphate and sodium hydrogen phosphate, adjust pH to 5.1, add 0.1% active carbon to stir 30 minutes, filtering active carbon, medicinal liquid is again through 0.45 μ m and 0.22 μ m filtering with microporous membrane, detect intermediate content, by cefobutazine sodium, every bottle of 40mg calculates loading amount.
According to testing requirement fill, after half tamponade, send in freezer dryer, be cooled to-40 ℃, be incubated 2 as a child, be slowly warming up to-5 ℃~0 ℃ sublimation drying, then be warming up to after 35 ℃, be incubated 3 hours, lyophilization finishes, outlet.
The preparation of embodiment tri-, Ceftezole sodium used for injection composite freeze-dried powder, in 1000.
Prescription:
Cefobutazine sodium 40g
Chitosan nano 39g
Water for injection 2000ml
2. preparation technology:
The chitosan nano that takes 39g slowly joins in the water for injection of 2000ml, stirs while adding to dissolving.
The cefobutazine sodium the extremely clarification of stirring and dissolving that add 40g.
With the buffer salt of sodium dihydrogen phosphate and sodium hydrogen phosphate, adjust pH to 5.1, add 0.1% active carbon to stir 30 minutes, filtering active carbon, medicinal liquid is again through 0.45 μ m and 0.22 μ m filtering with microporous membrane, detect intermediate content, by cefobutazine sodium, every bottle of 40mg calculates loading amount.
According to testing requirement fill, after half tamponade, send in freezer dryer, be cooled to-40 ℃, be incubated 2 as a child, be slowly warming up to-5 ℃~0 ℃ sublimation drying, then be warming up to after 35 ℃, be incubated 3 hours, lyophilization finishes, outlet.
Experimental data
1 materials and methods
1.1 material
1.1.1 medicine and reagent Ceftezole sodium used for injection (by A department, being produced), Ceftezole sodium used for injection (by the production of B department), embodiment mono-composition sample.
1.1.2 strain streptococcus pneumoniae.
1.1.3 culture medium plain agar and broth bouillon, according to a conventional method preparation.
1.2.3 extracorporeal bacteria inhibitor test
1.2.3.1 bacterium solution preparation is inoculated in the streptococcus pneumoniae strain of preservation in nutrient broth medium, in 37 ℃ of calorstats, cultivate after 20h, bacterium liquid is pressed 10 times of serial dilutions with normal saline, be inoculated in respectively agar plate, put 37 ℃ and cultivate 20h, calculate bacterium colony number, select suitable concn to make bacterial concentration at 105cfu/mL-106cfu/mL the dilution of bacterium liquid, standby.
1.2.3.2 minimum inhibitory concentration (MIC) is measured and is adopted 10 times of dilution methods of test tube.If A, B, tri-groups of test tubes of C, every group 11, compiling is in order No. 1-No. 11, each test tube all adds 4.5mL dilution bacterium liquid (bacterium liquid 105cfu/mL-106cfu/mL), the Ceftezole sodium used for injection (being produced by A department) that adds 0.5mL to prepare in No. 1 test tube of A group, the Ceftezole sodium used for injection (being produced by B department) that adds 0.5mL to prepare in No. 1 test tube of B group, embodiment mono-composition sample that adds 0.5mL to prepare in No. 1 test tube of C group, all by 10 times of dilution methods, be diluted to the 8th pipe, all establish medicine control tube for every group, bacterium liquid control tube and blank pipe, put in 37 ℃ of calorstats and cultivate, with ocular estimate and matched group comparison, as the medicinal liquid test tube that adds antibacterial is still clarification, indicate without bacterial growth, this pipe drug level has bacteriostasis, as be muddy, showing that antibacterial grows, this concentration medicine is without bacteriostasis.Using the complete lowest drug concentration without bacterial growth as antibacterial the sensitivity to this medicine, be this medicine MIC.
2, result and discussion
2.1 Ceftezole sodium used for injection (being produced by A department), Ceftezole sodium used for injection (being produced by B department), embodiment mono-composition sample all have inhibitory action in various degree to streptococcus pneumoniae, its MIC average is respectively: 2.4,2.1,0.5(g/L), and embodiment mono-composition sample antibacterial effect provided by the invention is obviously better than other two groups, present good antibacterial and bactericidal effect, have significant difference, clinic is applied.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what in above-described embodiment and description, describe is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.

Claims (2)

1. a Ceftezole sodium used for injection composite freeze-dried powder, is characterized in that, the material composition that comprises following weight portion:
7.26~9.17 parts of cefobutazine sodiums
5.78~7.67 parts of chitosan nanos
81.38~87.10 parts of waters for injection.
2. a preparation method for Ceftezole sodium used for injection composite freeze-dried powder described in claim 1, is characterized in that, comprises the steps:
(1) preparation of chitosan nano:
1) will after the pulverizing of chitosan powder, through 100 eye mesh screens, sieve;
2) the chitosan powder that takes 100g at room temperature adds 0.1mol/l acetic acid solution 40L, and magnetic agitation, dissolves chitosan completely, obtains chitosan acetic acid solution;
3) with 1%NaOH, regulate pH=5.0;
4) add 1% sodium tripolyphosphate 1667g to chitosan acetic acid solution under stirring, making chitosan/sodium tripolyphosphate mass ratio is 6:1, and the electrostatic interaction by zwitterion is cross-linked into nanoparticle;
5) by 4 ℃ of high speed centrifugation 30min of above-mentioned colloid solution, collect lower sediment, with after pure water washing 3 times, the dry chitosan nano that obtains of cooling final vacuum, moisture is lower than 2%, particle diameter≤100nm, zeta current potential is about 15mv;
(2) preparation of Ceftezole sodium used for injection composite freeze-dried powder:
1) chitosan nano of recipe quantity is slowly joined in the water for injection of recipe quantity, stir while adding to dissolving;
2) add cefobutazine sodium the extremely clarification of stirring and dissolving of recipe quantity;
3) with the buffer salt of sodium dihydrogen phosphate and sodium hydrogen phosphate, adjust pH to 5.1, add 0.1% active carbon to stir 30 minutes, filtering active carbon, medicinal liquid is again through 0.45 μ m and 0.22 μ m filtering with microporous membrane, detect intermediate content, by cefobutazine sodium, every bottle of 40mg calculates loading amount;
4) according to testing requirement fill, after half tamponade, send in freezer dryer, be cooled to-40 ℃, be incubated 2 as a child, be slowly warming up to-5 ℃~0 ℃ sublimation drying, then be warming up to after 35 ℃, be incubated 3 hours, lyophilization finishes, outlet.
CN201310481840.XA 2013-10-15 2013-10-15 Ceftezole sodium composition powder for injection Pending CN103536560A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310481840.XA CN103536560A (en) 2013-10-15 2013-10-15 Ceftezole sodium composition powder for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310481840.XA CN103536560A (en) 2013-10-15 2013-10-15 Ceftezole sodium composition powder for injection

Publications (1)

Publication Number Publication Date
CN103536560A true CN103536560A (en) 2014-01-29

Family

ID=49960678

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310481840.XA Pending CN103536560A (en) 2013-10-15 2013-10-15 Ceftezole sodium composition powder for injection

Country Status (1)

Country Link
CN (1) CN103536560A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319219A (en) * 2011-09-30 2012-01-18 四川金瑞克动物药业有限公司 Chitosan nanoparticle preparation of ceftiofur sodium, and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102319219A (en) * 2011-09-30 2012-01-18 四川金瑞克动物药业有限公司 Chitosan nanoparticle preparation of ceftiofur sodium, and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘慧: "《壳聚糖微球/纳米粒的制备及其性能研究》", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Similar Documents

Publication Publication Date Title
CN102871996B (en) Antibiotic composition and application thereof
CN110393725B (en) Phenylboronic acid with gram selectivity and gold nanoparticle modified by derivative of phenylboronic acid, and preparation method and application of phenylboronic acid and gold nanoparticle
CN111658668B (en) Functional antibacterial combination medicine and application
CN106424753A (en) Preparation and application of MnO2-Ag nanocomposite
CN1868478A (en) Compound prepn. injection contg. cefoperazone sodium and tazobactam sodium
CN109221104B (en) Silver-containing carbon dots, preparation method and application thereof
CN106967812A (en) A kind of screening technique of the positive bacterias of mcr 1
CN114099418A (en) Natural bioactive small molecule self-assembled luminous hydrogel and preparation method and application thereof
CN100502890C (en) Amoxicillin antibacterial agent containing nano silver, and its preparing method
CN103550176A (en) Fosfomycin sodium composition lyophilized powder for injection
CN103536617A (en) Ceftazidine composition freeze-dried powder for injection
CN103536560A (en) Ceftezole sodium composition powder for injection
CN103585117A (en) Cefotaxime sodium composition freeze-dried powder for injection
CN103536558A (en) Cefoperazone sodium composition freeze-dried powder for injection
CN103550247A (en) Cefpiramide sodium composition freeze-dried injection for injection
CN102670620B (en) Cefradine-borneol composition
CN103565759A (en) Ceftibuten composition freeze-dried powder for injection
CN100413962C (en) Extended-spectrum beta-lactamases Escherichia coli bacteriophage and its separation and preparation method
CN103536555A (en) Ceftriaxone sodium composition freeze-dried powder for injection
CN103550171A (en) Cefminox sodium composition freeze-dried powder injection for injection
CN112961246B (en) Nano microsphere anti-biofilm peptide CRAMP and preparation method and application thereof
CN102462683B (en) Antibiotic composition and preparation method and application thereof
CN103550177A (en) Cefpirome sulfate composition freeze-dried powder injection for injection
CN103536561A (en) Sulbactam sodium composition freeze-dried powder for injection
CN103550169A (en) Cefpodoxime proxetil composition freeze-dried powder injection for injection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140129